Actively Recruiting
PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer
Led by Hoag Memorial Hospital Presbyterian · Updated on 2021-07-27
184
Participants Needed
1
Research Sites
97 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The standard of care imaging of prostate cancer metastases recommended by the National Comprehensive Cancer Network (NCCN), CT of the chest/abdomen/pelvis and bone scan, may be suboptimal. PyL is a novel PET tracer designed to detect prostate specific membrane antigen (PSMA) expressed on prostate cancer cells. PyL PET/CT may provide improved evaluation of clinically significant metastases in patients with prostate cancer.
CONDITIONS
Official Title
PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male 18 years of age or older
- Histologically confirmed adenocarcinoma of the prostate
- Patients must meet one of the following:
- High risk prostate cancer (PSA >10, Gleason 8-10, or clinical stage >T2c) with planned prostatectomy or radiation therapy
- Biochemical recurrence with PSA >0.2 ng/ml after prostatectomy or ≥2 ng/ml above PSA nadir after radiotherapy, and no metastases on standard imaging within 3 months
You will not qualify if you...
- Any condition or abnormality that may compromise patient safety or data quality as judged by the investigator
- Inability to undergo PET/CT scanning due to weight limits (over 450 pounds)
- Change in therapy since standard of care imaging
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hoag Memorial Hospital Presbyterian
Irvine, California, United States, 92618
Actively Recruiting
Research Team
B
Beth Thomsen
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here